November 28, 2014 - WADA welcomes the decision by the Court of Arbitration for Sport (CAS) to uphold the appeal it filed against the decision of the Finnish appeal board to exonerate cross-country skier Juha Lallukka for an anti-doping rule violation (ADRV) relating to human Growth Hormone (hGH).

The decision to find the athlete had committed a rule violation and sanction the athlete for a period of two years fully answers all the issues raised by the CAS panel in the Andrus Veerpalu case. It also means there is no doubt surrounding the validity and reliability of the recently published version 2 of the Guidelines for the application of the human Growth Hormone (hGH) Isoform Differential Immunoassays for detection of doping with human Growth Hormone in sport.

WADA Director General, David Howman: “WADA is pleased that, in reaching its decision, CAS recognized that all issues raised by the Veerpalu case have now been answered in a “convincing manner”, and that WADA had fully met the burden of proof required for Mr. Lallukka to be sanctioned.

“WADA is glad that the issues relating to hGH testing have been resolved, and continues to encourage all anti-doping organizations to analyze samples as part of their regular anti-doping program.”

Related Story

• China's Sheng Lihao wins 2nd Paris Olympic gold with men's 10m air rifle victory(08-29 19:31)
• Olympics | Day 13: Chinese diver defends Olympic title, weightlifting debutant claims gold(08-09 16:50)
• Olympics | Chinese weightlifters Hou, Li retain gold at Paris 2024(08-08 14:26)
• Olympics | Day 12: Chinese weightlifters retain Olympic golds, artistic swimming team make history(08-08 14:23)
• Olympics | Chinese diver Quan defends women's 10m platform title at Paris Games(08-07 22:37)